Artiva Biotherapeutics, Inc. (ARTV)
10.85
+0.61
(+5.96%)
USD |
NASDAQ |
May 01, 16:00
10.85
0.00 (0.00%)
After-Hours: 16:35
Artiva Biotherapeutics EPS Diluted (Quarterly) : -0.8453 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Innoviva, Inc. | 1.944 |
| Rocket Pharmaceuticals, Inc. | -0.3805 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.77M |
| Total Expenses (Quarterly) | 20.77M |
| Enterprise Value | 154.27M |
| Earnings Yield | -31.62% |
| Normalized Earnings Yield | -31.62 |